POU3F3

ncRNA information

ncRNA name

POU3F3

Specific or universal ncRNAs

Specific ncRNAs

Class

Long noncoding RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

MiR-650/MGMT

Cancer information

Cancer name

Melanoma

Cancer site

qRT-PCR,Western blot,Luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Dacarbazine

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

198

Male patients

111

Female patients

155(<60)+154(>=60)

Age range and number

Not available

Research information

PMID

Description

LncRNA POU3F3 Contributes to Dacarbazine Resistance of Human Melanoma Through the MiR-650/MGMT Axis

Tissue resource

human melanoma cell lines A375

human melanoma cell lines MV3

Experiment

309


Institute

American Type Culture Collection

Country

United States

Continent

North Amercian